Universidad del País Vasco/Euskal Herriko Unibertsitatea-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2006

  1. In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: Comparison of CLSI M27-A2, Sensitive YeastOne, disk diffusion, and Etest methods

    Microbial Drug Resistance, Vol. 12, Núm. 4, pp. 246-251

2004

  1. Evaluation of API ID 32C® and VITEK-2® to identify Candida dubliniensis

    Diagnostic Microbiology and Infectious Disease, Vol. 50, Núm. 3, pp. 219-221

2003

  1. Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: A comparative study with M27-A microdilution method

    Journal of Antimicrobial Chemotherapy, Vol. 51, Núm. 1, pp. 163-166

  2. Performance of Bacticard™ Candida compared with the germ tube test for the presumptive identification of Candida albicans

    Mycoses, Vol. 46, Núm. 11-12, pp. 467-470

2000

  1. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole

    Chemotherapy, Vol. 46, Núm. 4, pp. 235-244

  2. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents

    Chemotherapy, Vol. 46, Núm. 6, pp. 395-401

1999

  1. Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing

    Revista Iberoamericana de Micologia, Vol. 16, Núm. 2, pp. 92-96

1996

  1. Aportaciones del comité de la AEM para la estandarización de pruebas de estudio de la sensibilidad in vitro a los antifúngicos: Método de difusión en disco

    Revista Iberoamericana de Micologia, Vol. 13, Núm. SUPPL. 2